Serum oestradiol levels and risk of adverse cardiovascular events associated with gender-affirming oestrogen therapy: a protocol for a systematic review and meta-analysis.

Chantal L RytzKeila Turino MirandaPaul E RonksleySandra M DumanskiNathalie SaadSatish R RajRanjani SomayajiHeather GanshornAmelia M NewbertLindsay PeaceSofia B Ahmed

Published in: BMJ open (2022)

CRD42021247717.

Keyphrases

cardiovascular events
coronary artery disease
cardiovascular disease
randomized controlled trial
mental health
stem cells
emergency department
type diabetes
adverse drug
drug induced